Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;68(4):735-745.
doi: 10.1007/s11686-023-00713-x. Epub 2023 Aug 17.

Thymoquinone Effect on Leishmania tropica/infantum and Leishmania-Infected Macrophages

Amir KarimiPourSaryazdi #  1 , Mohammad Mahdi Jafari #  2 , Majid Pirestani  3 , Seyyed Hojjat Sadeghi  4 , Zeinab Moghadamizad  1
Affiliations

Thymoquinone Effect on Leishmania tropica/infantum and Leishmania-Infected Macrophages

Amir KarimiPourSaryazdi et al. Acta Parasitol. 2023 Dec.

Abstract

Introduction: Leishmania is a parasitic protozoan that tries to enter and amplify within macrophages. Macrophage cells are also immune defense cells that phagocyte many microbes like bacteria, fungi, as well as parasites like Leishmania spp. However, they are unable to kill this parasite that resides in the phagosomes of contaminated macrophages and multiplies in these macrophages, leading to the destruction of contaminated macrophages and the emerging of Leishmania wounds. A large number of current therapies for Leishmania cure have adverse effects, or parasites have developed resistance to some of these therapies, so a better therapy for the cure of Leishmania is required. Thymoquinone is one of the Nigella Sativa ingredients with numerous biological effects, such as antioxidant as well as antimicrobial effects on a variety of microbes, namely fungi, bacteria, as well as parasites like Leishmania spp. The impacts of Thymoquinone on Leishmania tropica and Leishmania infantum, as well as Leishmania-infected macrophages, were examined in this study.

Methods: The impact of various Thymoquinone dosages on L. tropica and L. infantum promastigotes and amastigotes was examined in vitro. Flow cytometry, as well as MTT, was also applied to examine the cytotoxic activity of Thymoquinone on promastigotes of L. tropica and L. infantum, as well as the incidence of apoptosis. The amastigote assay is also utilized to calculate the % of contaminated macrophages as well as the number of the present parasites in each macrophage.

Results: The percentage of macrophages contaminated with L. tropica and L. infantum amastigotes after medicating with 20 μM of Thymoquinone was 23% and 19%, respectively. Also, after medicating with 10 μM of Thymoquinone, these percentages were 32% and 31%, respectively. Flow cytometry indicated that Thymoquinone caused 33.9% and 31.4% apoptosis in L. tropica and L. infantum, respectively. As determined by the promastigote assay, the inhibitory concentration (IC50) of Thymoquinone for L. tropica and L. infantum was 9.49 μM and 12.66 μM, respectively. The results of the promastigote and amastigote assay show that with an increase in Thymoquinone doses, its ability to kill Leishmania parasites increases, too.

Conclusion: According to the results of the study, Thymoquinone has a potentially lethal impact on L. tropica and L. infantum promastigotes as well as amastigotes (within leishmania contaminated macrophages).

Keywords: L. tropica; Leishmania infantum; Leishmania-infected macrophages; Thymoquinone.

PubMed Disclaimer

References

    1. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305–318. https://doi.org/10.1016/j.cimid.2004.03.004 - DOI
    1. Kadkhodamasoum S, Bineshian F, KarimiPour A, Tavakoli P, Foroutan M, Ghaffarifar F, Molaei S (2019) Comparison of the effects of sambucus ebulus leaf and fruit extracts on leishmania major In Vitro. Infect Disord Drug Targets 21:49–54. https://doi.org/10.2174/1871526520666191220114540 - DOI
    1. Karimkhani C, Wanga V, Coffeng LE, Naghavi P, Dellavalle RP, Naghavi M (2016) Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the global burden of disease study 2013. Lancet Infect Dis 16:584–591. https://doi.org/10.1016/S1473-3099(16)00003-7 - DOI
    1. Pasandideh R, Dadmanesh M, Khalili S, Mard-Soltani M, Ghorban K (2020) In silico molecular modeling and docking studies on the Leishmania mitochondrial iron transporter-1 (LMIT1). Comp Clin Path 29:115–125. https://doi.org/10.1007/s00580-019-03033-7 - DOI
    1. Strazzulla A, Cocuzza S, Pinzone MR, Postorino MC, Cosentino S, Serra A, Cacopardo B, Nunnari G (2013) Mucosal leishmaniasis: an underestimated presentation of a neglected disease. Biomed Res Int. https://doi.org/10.1155/2013/805108 - DOI - PMC

LinkOut - more resources